Ibex Investors LLC bought a new stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,743 shares of the company’s stock, valued at approximately $207,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Acadian Asset Management LLC bought a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at approximately $106,000. Harvest Fund Management Co. Ltd bought a new stake in U.S. Physical Therapy in the third quarter worth $190,000. Cambridge Investment Research Advisors Inc. bought a new stake in U.S. Physical Therapy in the second quarter worth $219,000. Itau Unibanco Holding S.A. bought a new stake in U.S. Physical Therapy in the second quarter worth $235,000. Finally, PNC Financial Services Group Inc. lifted its position in U.S. Physical Therapy by 62.7% in the second quarter. PNC Financial Services Group Inc. now owns 2,676 shares of the company’s stock worth $256,000 after buying an additional 1,031 shares during the last quarter. Hedge funds and other institutional investors own 99.58% of the company’s stock.
In other news, Director Mark J. Brookner sold 500 shares of U.S. Physical Therapy stock in a transaction on Friday, November 16th. The stock was sold at an average price of $118.50, for a total transaction of $59,250.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Lawrance W. Mcafee sold 3,100 shares of U.S. Physical Therapy stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $113.29, for a total value of $351,199.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,100 shares of company stock valued at $927,949. 2.50% of the stock is owned by corporate insiders.
Shares of USPH opened at $111.63 on Friday. The firm has a market capitalization of $1.39 billion, a P/E ratio of 53.67, a P/E/G ratio of 3.81 and a beta of 1.21. U.S. Physical Therapy, Inc. has a 52-week low of $70.10 and a 52-week high of $129.65. The company has a quick ratio of 1.93, a current ratio of 1.93 and a debt-to-equity ratio of 0.26.
U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.06. The company had revenue of $113.10 million during the quarter, compared to the consensus estimate of $112.79 million. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. U.S. Physical Therapy’s quarterly revenue was up 9.8% on a year-over-year basis. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.55 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Friday, December 7th. Investors of record on Friday, November 9th were given a $0.23 dividend. The ex-dividend date was Thursday, November 8th. This represents a $0.92 dividend on an annualized basis and a yield of 0.82%. U.S. Physical Therapy’s dividend payout ratio is presently 44.23%.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Story: Relative Strength Index
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.